Feedback PLC (LON:FDBK) told investors that its Bleepa system has been rolled out across the Pennine Acute Hospitals (PAH) NHS Trust to help its coronavirus (COVID-19) response.
The key patient management tool, which includes secure medical image communication, is being used by clinical staff on the front-line, the company said.
It means that chest X-rays and CT scans are more easily accessible, both remotely and for those on the frontline.
Some 200 frontline clinicians within the Acute Medical Team have now been enrolled on Bleepa and more users will be onboarded in the coming week, the company added in a statement.
READ: Bleepa under evaluation as potential coronavirus tool
The PAH NHS trust was already familiar Bleepa, having piloted the platform within the Respiratory inpatient referral pathway for several months, and Feedback has honed the tool with new features, developed at pace, specifically to support the clinical teams combatting COVID-19.
Feeback noted that the new unique features can facilitate key decision processes, by connecting clinical decision-makers with frontline personnel and making relevant imaging available at the push of a button.
At the same time, it said, Bleepa captures the clinical dialogue and decision making processes, subsequently forming part of the patient record after the admission is completed.
“It will become increasingly important for clinicians to have timely access to medical imaging and other team members especially in light of a growing requirement for remote access due to self-isolation," said Tom Oakley, Feedback chief executive.
“Bleepa is the only imaging communication tool that can deliver the required workflow support at the scale required and it's not just Radiologists who need access to imaging now but all frontline personnel.”
Georges Ng Man Kwong, a consultant chest physician working in the trust, meanwhile noted that Bleepa was also identified as being a secure solution to register and identify patients suitable for the RECOVERY trial - a national randomised study looking at novel covid treatments – as well as being a communication and decision making aid.
He added: “It has rapidly been adopted by our research nurses and clinician specialists in key acute areas across the hospital providing additional opportunities to identify and track patients receiving respiratory and palliative care respectively."
“Our on-going engagement with Bleepa continues to identify additional specialities and scope to widen its' application within our health-care organisation that will aid clinicians both during this challenging period and once the pandemic crisis has ended."
The whole Company feels deeply privileged to be able to help and we are immensely proud to see our tool deployed and already making a difference to delivery at this time.
We will work hard to ensure that Bleepa can support and protect as many frontline NHS staff as possible and we are already looking to support other NHS Trusts who would similarly benefit from our system."
